P0133 DEPECA-1 (DEfeating PEnile CAncer 1) – a Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma

European Urology 2026

View at publisher
Authors: I. Tsaur, M.L. Barcena, Y.S. Feng, L. Eismann, C. S. Thomas, Christiane Gäbel, D.W. Müller, S.E. Al-Batran, A. Thomas, A. Borkowetz, Benjamin Meister, M. Schnabel
+5 more M. Retz, Maximillian Reimann, G. Niegisch, Eva Erne, S. Rausch
DOI: 10.1016/s0302-2838(26)01042-0
Cited by: 0

Fields of Study & Subjects

Genital Health and Disease Bladder and Urothelial Cancer Treatments Nonmelanoma Skin Cancer Studies

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S1
Publication date
13 February 2026
Language
EN